Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Suprapubic Single-incision Laparoscopic Appendectomy Versus Conventional Appendectomy: a Randomized Controlled Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02499016
Recruitment Status : Unknown
Verified March 2015 by Nanfang Hospital of Southern Medical University.
Recruitment status was:  Recruiting
First Posted : July 15, 2015
Last Update Posted : July 15, 2015
Sponsor:
Information provided by (Responsible Party):
Nanfang Hospital of Southern Medical University

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Conventional laparoscopic appendectomy(CLA) is the current standard treatment. To obtain additional benefits such as a better cosmetic outcome, the investigators developed a surgical option termed suprapubic single-incision laparoscopic appendectomy (SSILA), which creates a non-visible scar, that was preliminarily shown to be feasible and safe in our previous retrospective studies To further evaluate the feasibility, safety and cosmetic results of this innovative approach, the investigators compared the outcomes of SSILA and CLA by performing a randomized controlled trial.

Condition or disease Intervention/treatment Phase
Complications Procedure: suprapubic single-incision laparoscopic appendectomy Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 208 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Suprapubic Single-incision Laparoscopic Appendectomy Versus Conventional Multiport Appendectomy: a Randomized Controlled Trial
Study Start Date : June 2015
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : December 2018
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: suprapubic single-incision laparoscopic appendectomy
single incision laparoscopic surgery will be performed for patients in this group.
 Procedure: suprapubic single-incision laparoscopic appendectomy
the approach of appendectomy
Other Name: SSILA
Active Comparator: conventional multiport appendectomy
Conventional laparoscopic surgery will be performed for patients in this group.
 Procedure: suprapubic single-incision laparoscopic appendectomy
the approach of appendectomy
Other Name: SSILA


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. incidence of complications [ Time Frame: 30 days ]
    The early morbidity rate is defined as the event observed during operation and within 30 days after surgery


Secondary Outcome Measures :
  1. mortality rate [ Time Frame: 30 days ]
  2. cosmetic results [ Time Frame: 30 days ]
    Cosmetic assessment is perform using body image scale and cosmetic scale.

  3. operative time [ Time Frame: intraoperative ]
  4. time to recover [ Time Frame: 14 days ]
  5. Pain score [ Time Frame: 14 days ]
    Postoperative pain is recorded using the visual analog scale (VAS) pain score tool on postoperative day 1, 2, 3 and the day of discharge.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • acute appendicitis or interval appendicitis
  • informed consent

Exclusion Criteria:

  • diagnosis of appendicitis was not clinically established (symptoms attributable to urinary or gynecological problems)
  • history of cirrhosis and coagulation disorders
  • suspected or proven malignancy
  • contraindication to general anesthesia (severe cardiac and/or pulmonary disease)
  • inability to give informed consent(severe mental disease)
  • pregnancy
  • BMI>30kg/m2
  • generalized peritonitis
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02499016


Contacts
Layout table for location contacts
Contact: Guoxin Li, M.D.,Ph. D. +86-138-0277-1450 gzliguoxin@163.com
Contact: Yanan Wang, M.D +86-150-1875-3181 wyn8116@163.com

Locations
Layout table for location information
China, Guangdong
Nanfang Hospital, Southern Medical University Recruiting
Guangzhou, Guangdong, China, 510-515
Contact: Guoxin Li, M.D., Ph.D.    +86-138-0277-1450    gzliguoxin@163.com   
Contact: Yanan Wang, M.D.    +86-150-1875-3181    wyn8116@163.com   
Principal Investigator: Guoxin Li, M.D.,Ph.D.         
Sponsors and Collaborators
Nanfang Hospital of Southern Medical University
Investigators
Layout table for investigator information
Principal Investigator: Guoxin Li, M.D.,Ph. D. Nanfang Hospital, Southern Medical University, China
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications of Results:

Layout table for additonal information
Responsible Party: Nanfang Hospital of Southern Medical University
ClinicalTrials.gov Identifier: NCT02499016    
Other Study ID Numbers: NFGS-SSILA-01
First Posted: July 15, 2015    Key Record Dates
Last Update Posted: July 15, 2015
Last Verified: March 2015
Keywords provided by Nanfang Hospital of Southern Medical University:
Appendicitis
Appendectomy
Single-incision
Additional relevant MeSH terms:
Layout table for MeSH terms
Surgical Wound
Wounds and Injuries